Abstract:BACKGROUND:Previous research has identified functional impairments within the prefrontal-limbic circuit in individuals with anxiety disorders. However, the link between these deficiencies, clinical symptoms, and responses to antipsychotic treatment is still not fully understood. This study aimed to investigate abnormal regional activity within the prefrontal-limbic circuit among drug-naive individuals diagnosed with generalized anxiety disorder (GAD) and panic disorder (PD) and to analyze changes following treatment.METHODS:Resting-state magnetic resonance imaging was performed on a cohort of 118 anxiety disorder patients (64 GAD, 54 PD) and 61 healthy controls (HCs) at baseline. Among them, 52 patients with GAD and 44 patients with PD underwent a 4-week treatment regimen of paroxetine. Fractional amplitude of low-frequency fluctuation (fALFF) measurements and pattern classification techniques were employed to analyze the data in accordance with the human Brainnetome atlas.RESULTS:Both patients with GAD and PD demonstrated decreased fALFF in the right cHipp subregion of the hippocampus and increased fALFF in specified subregions of the cingulate and orbitofrontal lobe. Notably, patients with PD exhibited significantly higher fALFF in the left A24cd subregion compared to patients with GAD, while other ROI subregions showed no significant variations between the two patient groups. Whole-brain analysis revealed abnormal fALFF in both patient groups, primarily in specific areas of the cingulate and parasingulate gyrus, as well as the inferior and medial orbitofrontal gyrus (OFG). Following a 4-week treatment period, specific subregions in the GAD and PD groups showed a significant decrease in fALFF. Further analysis using support vector regression indicated that fALFF measurements in the right A13 and right A24cd subregions may be predictive of treatment response among anxiety disorder patients.CONCLUSIONS:Aberrant functional activity in certain subregions of the prefrontal-limbic circuit appears to be linked to the manifestation of anxiety disorders. These findings suggest potential imaging indicators for individual responses to antipsychotic treatment.

Abnormal Cortical Surface Projections of Thalamus in Patients with Schizophrenia

Altered Effective Connectivity in the Default Network of the Brains of First-Episode, Drug-Naïve Schizophrenia Patients with Auditory Verbal Hallucinations

Abnormal Dynamic Functional Connectivity Density in Patients with Generalized Anxiety Disorder.

White Matter Integrity Alterations in First Episode, Treatment-Naive Generalized Anxiety Disorder

Dynamic Changes of Amplitude of Low-Frequency Fluctuations in Patients with Generalized Anxiety Disorder.

Alternations in Cortical Thickness and Functional Connectivity in Patients with Generalized Anxiety Disorder

Abnormal hemispheric specialization and inter-hemispheric functional cooperation in generalized anxiety disorder

Amygdala-Based Structural Covariance and Functional Connectivity Alterations in Patients with Generalized Anxiety Disorder.

Disrupted Interhemispheric Resting-State Functional Connectivity and Structural Connectivity in First-Episode, Treatment-Naïve Generalized Anxiety Disorder.

Alterations in neural circuit dynamics between the limbic network and prefrontal/default mode network in patients with generalized anxiety disorder

Abnormal cortical complexity of first-episode treatment-naive schizophrenia patients

Abnormal large-scale brain functional network dynamics in social anxiety disorder

Abnormal Regional Activity in the Prefrontal-Limbic Circuit at Rest: Potential Imaging Markers and Treatment Predictors in Drug-Naive Anxiety Disorders.

Aberrant Functional Connectivity between the Amygdala and the Temporal Pole in Drug-Free Generalized Anxiety Disorder

Disrupted Dynamic Local Brain Functional Connectivity Patterns in Generalized Anxiety Disorder

Large-scale Dysfunctional White Matter and Grey Matter Networks in Patients with Social Anxiety Disorder

Enhanced Temporal Variability of Amygdala-Frontal Functional Connectivity in Patients with Schizophrenia

Abnormal Causal Connectivity of Prefrontal-Limbic Circuit by Structural Deﬁcits in Drug-Naive Anxiety Disorders

Differential Alterations of Resting-State Functional Connectivity in Generalized Anxiety Disorder and Panic Disorder.

Abnormal causal connectivity of prefrontal-limbic circuit by structural deficits in drug-naive anxiety disorders

Aberrant dynamic functional connectivity of thalamocortical circuitry in major depressive disorder